IFI30 and breast cancer: This conflicting observation between mRNA and protein levels of GILT in breast cancer was quite different from what have found in Diffuse Large B-Cell Lymphoma (DLBCL), which demonstrated that variation in GILT protein expression correlated strongly with its mRNA expression within tumor cells [39].